Carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRAB) is one of
the top-priority pathogens for new antibiotic development. Unlike other antibiotic-resistant …

Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …

We report on 11 critically ill burn patients treated with cefiderocol for carbapenem-resistant
Acinetobacter baumannii infections. Clinical success was achieved in 36% and complicated …

What is known and objective Acinetobacter baumannii is one of the most important
nosocomial pathogens with the ability to cause infections such as meningitis, pneumonia …

Carbapenem-resistant Acinetobacter baumannii (CRAB) has been classified by the World
Health Organization as being in the critical category of pathogens requiring urgent new …

There is growing concern among healthcare providers worldwide regarding the prevalence
of multidrug-resistant Acinetobacter baumannii (A. baumannii). Some of the worst hospital …

Antimicrobial resistance represents a serious threat for global health, causing an
unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in …

With the current crisis related to the emergence of carbapenem-resistant Gram-negative
bacteria (CR-GNB), classical treatment approaches with so-called “old-fashion antibiotics” …

Abstract Background Carbapenem-resistant Acinetobacter baumannii (CRAB) infections are
associated with high mortality rates. The optimal treatment regimen for CRAB has not been …

Following the observation of an increased number of isolation of OXA-23-and ArmA-
producing Acinetobacter baumannii at the national level, our aim was to evaluate whether …